Product nameAnti-ELL antibody
See all ELL primary antibodies
DescriptionRabbit polyclonal to ELL
Tested applicationsSuitable for: IPmore details
Unsuitable for: WB
Species reactivityReacts with: Human
Synthetic peptide within Human ELL aa 350-400. The exact sequence is proprietary.
Database link: P55199
- IP: HeLa whole cell lysate.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.09% Sodium azide
Constituent: Tris citrate/phosphate
Concentration information loading...
Our Abpromise guarantee covers the use of ab264218 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IP||Use a concentration of 2 - 10 µg/ml.|
RelevanceELL was shown to encode an elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. ELL is the second elongation factor to be implicated in oncogenesis.
Cellular localizationNuclear. Colocalizes with EAF2 to nuclear speckles and to Cajal bodies.
- eleven nineteen lysine rich leukemia gene antibody
- Eleven-nineteen lysine-rich leukemia protein antibody
- ELL1 antibody
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab264218 has not yet been referenced specifically in any publications.